Global Neurology Academy

Continuum of Care: Managing DMD in Pediatric and Adult Patients
Continuum of Care: Managing DMD in Pediatric and Adult Patients
NeuroFrontiers
Continuum of Care: Managing DMD in Pediatric and Adult Patients
- John F. Brandsema, MD
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
NeuroFrontiers
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
- John F. Brandsema, MD
How DDL-920 Could Help Restore Cognitive Function in Alzheimer's Patients
How DDL-920 Could Help Restore Cognitive Function in Alzheimer's Patients
NeuroFrontiers
How DDL-920 Could Help Restore Cognitive Function in Alzheimer's Patients
- Ashley Baker, MSN, PMHNP
- Istvan Mody, PhD
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
CME/CE
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
1.00 credit
- Perry Shieh, MD, PhD
1.00 credit
The Silent Struggle: Understanding ADHD's Impact on Girls and Women
The Silent Struggle: Understanding ADHD's Impact on Girls and Women
NeuroFrontiers
The Silent Struggle: Understanding ADHD's Impact on Girls and Women
- Kathleen Nadeau, PhD
Addressing ADHD in Women: A Guide to Diagnosis and Treatment
Addressing ADHD in Women: A Guide to Diagnosis and Treatment
NeuroFrontiers
Addressing ADHD in Women: A Guide to Diagnosis and Treatment
- Ashley Baker, MSN, PMHNP
- Kathleen Nadeau, PhD
Reviewing the Treatment Landscape for Duchenne Muscular Dystrophy
Reviewing the Treatment Landscape for Duchenne Muscular Dystrophy
NeuroFrontiers
Reviewing the Treatment Landscape for Duchenne Muscular Dystrophy
- Charles Turck, PharmD, BCPS, BCCCP
- Kay Davies, PhD, DBE FMedSci FRS
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
CME/CE
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
1.00 credit
- Craig M. McDonald, MD
- Crystal Proud, MD
- Aravindhan Veerapandiyan, MD
1.00 credit

Medical News

Medical News
Case Western Reserve Awarded $3.3M NIH Grant to Investigate Brain Proteins in Alzheimer’s Disease
thedaily.case.edu
10/04/2024
Read more
Medical News
Experts Call for Nutrition Education Overhaul in U.S. Medical Schools
hsph.harvard.edu
10/04/2024
Read more
Medical News
New Insights Into How the Brain Combines Pain Expectations and Stimuli
medicalxpress.com
10/01/2024
Read more
Medical News
Falls in Older Adults May Signal Early Dementia Risk
medicalxpress.com
10/01/2024
Read more

See more news

CME/CE

Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
CME/CE
Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
1.00 credit
- Michael Erdman, PharmD, BCCCP
- Ali A. Habib, MD
1.00 credit
ATTRv-PN: A Family Affair?
ATTRv-PN: A Family Affair?
MinuteCE®
ATTRv-PN: A Family Affair?
1.00 program credit
- John Berk, MD
- Noel Dasgupta, MD, FACC
1.00 program credit
Diagnosing ATTRv-PN: What's in Your Toolbox?
Diagnosing ATTRv-PN: What's in Your Toolbox?
MinuteCE®
Diagnosing ATTRv-PN: What's in Your Toolbox?
1.00 program credit
- Sami Khella, MD
1.00 program credit
ATTR Amyloidosis: Familial Vs Wild-Type
ATTR Amyloidosis: Familial Vs Wild-Type
MinuteCE®
ATTR Amyloidosis: Familial Vs Wild-Type
1.00 program credit
- Noel Dasgupta, MD, FACC
1.00 program credit

Clinical Practice

The Impact of a Cholesterol-Lowering Medication on Alzheimer's Disease
The Impact of a Cholesterol-Lowering Medication on Alzheimer's Disease
NeuroFrontiers
The Impact of a Cholesterol-Lowering Medication on Alzheimer's Disease
- Charles Turck, PharmD, BCPS, BCCCP
- Dr. Robert J. Shmookler Reis, PhD
- Dr. Srinivas Ayyadevara, PhD
Evaluating Endocrine Complications in DMD Patients: Findings from a Survey
Evaluating Endocrine Complications in DMD Patients: Findings from a Survey
NeuroFrontiers
Evaluating Endocrine Complications in DMD Patients: Findings from a Survey
- Charles Turck, PharmD, BCPS, BCCCP
- Nadia Merchant, MD
- Melody Shi, MD
- Despoina Galetaki, MD
Managing NF1 PN with this First and Only FDA-Approved Treatment Option
Managing NF1 PN with this First and Only FDA-Approved Treatment Option
NeuroFrontiers
Managing NF1 PN with this First and Only FDA-Approved Treatment Option
- Sandy Millman
- Pinki Prasad, MD
Understanding the Cardiovascular Risks of ADHD Medications
Understanding the Cardiovascular Risks of ADHD Medications
NeuroFrontiers
Understanding the Cardiovascular Risks of ADHD Medications

Programs

Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
NeuroFrontiers
Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
- Charles Turck, PharmD, BCPS, BCCCP
- John F. Brandsema, MD
Researching the Overlap: Hepatic Encephalopathy and Dementia in Focus
Researching the Overlap: Hepatic Encephalopathy and Dementia in Focus
NeuroFrontiers
Researching the Overlap: Hepatic Encephalopathy and Dementia in Focus
- Charles Turck, PharmD, BCPS, BCCCP
- Jasmohan Bajaj, MD
Public Health Disparities in Alzheimer's Disease and Brain Health
Public Health Disparities in Alzheimer's Disease and Brain Health
NeuroFrontiers
Public Health Disparities in Alzheimer's Disease and Brain Health
The Multiple Faces of ATTRv-PN
The Multiple Faces of ATTRv-PN
MinuteCE®
The Multiple Faces of ATTRv-PN
1.00 program credit
- Sami Khella, MD
- Marcia Waddington-Cruz, MD, PhD
1.00 program credit